» Articles » PMID: 39688442

Genetic Study on Candidates for Oocyte Donation

Overview
Date 2024 Dec 17
PMID 39688442
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: There is a rising demand for assisted reproductive medicine, including sperm, oocyte and embryo donation. Besides medical and legal considerations, genetic testing, including carrier screening for multiple autosomal and X-linked recessive disorders plays an essential role in evaluating hereditary risk among donors and therefore exclude them from the donation process.

Methods: A retrospective study was conducted on oocyte donors from a private clinic of assisted reproduction who underwent genetic testing between June 2014 and September 2023. Pre and post-test procedures were performed at the private clinic while karyotyping and carrier screening for Cystic Fibrosis, Fragile X syndrome and Spinal Muscular Atrophy were performed at the Genetic Unit of Faculty of Medicine, University of Porto.

Results: Among 581 donors, 81 women were excluded from the donation process since 5/563 had an alteration in karyotype, 57/581 were carriers of a Cystic Fibrosis Transmembrane conductance Regulator pathogenic variant or had a 5T allele, 11/394 had Survival of Motor Neuron 1 deletion and 8/426 had an intermediate or premutation allele in Fragile X Messenger Ribonucleoprotein gene. While recommendations from fertility societies advocate for comprehensive screening, opinions differ on the mandatory implementation of expanded carrier screening.

Conclusions: In conclusion, the genetic tests and the pre and post-test counseling is imperative to optimize reproductive outcomes in the oocyte donation process.

References
1.
Archibald A, Smith M, Burgess T, Scarff K, Elliott J, Hunt C . Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genet Med. 2017; 20(5):513-523. DOI: 10.1038/gim.2017.134. View

2.
Zhang J, Wang Y, Ma D, Sun Y, Li Y, Yang P . Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women. J Mol Diagn. 2020; 22(6):817-822. DOI: 10.1016/j.jmoldx.2020.03.001. View

3.
Pennings G . Expanded carrier screening should not be mandatory for gamete donors. Hum Reprod. 2020; 35(6):1256-1261. DOI: 10.1093/humrep/deaa088. View

4.
. Recommendations for practices using gestational carriers: a committee opinion. Fertil Steril. 2022; 118(1):65-74. DOI: 10.1016/j.fertnstert.2022.05.001. View

5.
Bobadilla J, Macek Jr M, Fine J, Farrell P . Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat. 2002; 19(6):575-606. DOI: 10.1002/humu.10041. View